成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Drugs Influencing Immune Function>Immunomodulators>Imiquimod
Imiquimod
  • Imiquimod

Imiquimod NEW

Price $37 $50 $68
Package 50mg 100mg 200mg
Min. Order:
Supply Ability: 10g
Update Time: 2024-11-19

Product Details

Product Name: Imiquimod CAS No.: 99011-02-6
Purity: 99.66% Supply Ability: 10g
Release date: 2024/11/19

Product Introduction

Bioactivity

NameImiquimod
DescriptionImiquimod (R 837) is an immune response modifier that acts as a toll-like receptor 7 agonist.
In vivoIn animal models, imiquimod stimulates the innate immune response by increasing NK cell activity, activating macrophages to secrete cytokines and nitric oxide, and inducing proliferation and differentiation of B lymphocytes. Imiquimod stimulates the innate immune response through induction, synthesis, and release of cytokines, including interferon-a (IFN-α), interleukin (IL)-6, and tumour necrosis factor (TNF)-α[1].
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility InformationH2O : Insoluble
KeywordsBowen's | R-837 | intraepithelial | carcinoma | Autophagy | basal ,cell | inhibit | Toll-like Receptor (TLR) | contagiosum | molluscum | SARS-CoV | S26308 | keratosis | vulvar | Herpes simplex virus | HSV | warts | actinic | infection | disease | R837 | squamous | human | cell | S 26308 | nongenital | SARS coronavirus | neoplasia | papillomavirus | Imiquimod | Inhibitor
Inhibitors RelatedStavudine | Sodium 4-phenylbutyrate | Hydroxychloroquine | Guanidine hydrochloride | Taurine | Paeonol | Naringin | Gefitinib
Related Compound LibrariesBioactive Compound Library | Membrane Protein-targeted Compound Library | EMA Approved Drug Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Active Compound Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$10.00/1KG
VIP6Y
Hebei Weibang Biotechnology Co., Ltd
2024-11-29
$37.00/50mg
VIP1Y
TargetMol Chemicals Inc.
2024-11-19
$1000.00/1ton
VIP1Y
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
2024-08-14
$0.10/1KG
VIP6Y
Shaanxi Dideu Medichem Co. Ltd
2024-07-05
$15.00/1kg
Ouhuang Engineering Materials (Hubei) Co., Ltd
2024-04-23
$1107.00/1kg
VIP3Y
Hebei Dangtong Import and export Co LTD
2023-09-15
$25.00/1kg
Anhui Ruihan Technology Co., Ltd
2023-08-22
$0.00/25KG
VIP5Y
Hebei Mojin Biotechnology Co., Ltd
2022-07-13
$1.00/1KG
XINGTAI XINGJIU NEW MATERIAL TECHNOLOGY CO., LTD
2021-12-31
$15.00/1KG
Qiuxian Baitai New Material Co., LTD
2021-11-26
  • Since: 2011-01-07
  • Address: 36?Washington?Street, Wellesley?Hills
INQUIRY